STOK
NASD Stoke Therapeutics, Inc.$25.88 ↑ +0.00 (+0.00%) Trading Up from the previous close of $25.88, $0.11 below the day’s high of $25.99
- YTD change
- -18.46%
- vs 20-day SMA
- -9.62%
- vs 200-day SMA
- -18.61%
Price ranges
Price & Performance
-5.89 (-18.54%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 63.8% away from all-time highs of $71.58
- STOK is down 18% since the beginning of the year
- STOK is up 5% over the past 12 months
- STOK is down 18% over the past 1 month
- 21% of all STOK investors are betting against STOK
STOK reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +10.1%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -7.74%
- vs 8-day SMA
- -4.29%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
